Patents by Inventor Stephen G. Rogers

Stephen G. Rogers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8334139
    Abstract: This invention relates to several plasmids which are useful for genetically transforming plant cells. A first plasmid, such as pMON120, contains a T-DNA border, one or more marker genes, a unique cleavage site, and a region of Ti plasmid homology. A gene which is expressed in plant cells may be inserted into this plasmid to obtain a derivative plasmid, such as pMON128 which expresses neomycin phosphotransferase in plant cells. The derivative plasmid is inserted into a suitable microorganism, such as A. tumefaciens which contains a Ti plasmid. The inserted plasmids recombine with Ti plasmids to form co-integrate plasmids. Only a single crossover event is required to create the desired co-integrate plasmid. A. tumefaciens cells with co-integrate plasmids are selected and co-cultured with plant cells. The co-integrate Ti plasmids enter the plant cells and insert a segment of T-DNA which does not contain tumorigenic genes into the plant genome.
    Type: Grant
    Filed: October 4, 1985
    Date of Patent: December 18, 2012
    Assignee: Monsanto Technology LLC
    Inventors: Robert T. Fraley, Stephen G. Rogers
  • Patent number: 8273954
    Abstract: This invention relates to genetically transformed, non-tumorous plant cells. A modified Ti plasmid is created which contains a left T-DNA border, one or more desired genes, and a right T-DNA border. This region does not contain tumorigenic or phytohormone-altering genes. The Ti plasmid is inserted into plant cells, where the T-DNA region is transferred into the plant genome. The transformed plant cells may be regenerated into morphologically normal plants which will pass the desired gene(s) to their descendants.
    Type: Grant
    Filed: October 30, 1985
    Date of Patent: September 25, 2012
    Assignee: Monsanto Technology LLC
    Inventors: Stephen G. Rogers, Robert B. Horsch, Robert T. Fraley
  • Patent number: 6608241
    Abstract: The invention involves recombinant, double-stranded DNA that contains a promoter which functions in plant cells to cause the production of RNA sequences of a plant virus, a DNA sequence that causes the production of an RNA sequence encoding the coat protein of said plant virus, and a 3′ non-translated region which functions in plant cells to cause the addition of polyadenylated nucleotides to the 3′ end of said RNA sequence; which double-stranded DNA can be used in a method for genetically transforming plants to produce genetically transformed plant cells and plants that are resistant to virus infection.
    Type: Grant
    Filed: October 9, 1986
    Date of Patent: August 19, 2003
    Assignees: Monsanto Technology LLC, Washington University
    Inventors: Roger N. Beachy, Robert T. Fraley, Stephen G. Rogers
  • Patent number: 6174724
    Abstract: This invention relates to chimeric genes which are capable of being expressed in plant cells. Such genes contain (a) a promoter region derived a gene which is expressed in plant cells, such as the nopaline synthase gene; (b) a coding or structural sequence which is heterologous with respect to the promoter region; and (c) an appropriate 3′ non-translated region. Such genes have been used to create antibiotic-resistant plant cells; they are also useful for creating herbicide-resistant plants, and plants which contain mammalian polypeptides.
    Type: Grant
    Filed: May 4, 1995
    Date of Patent: January 16, 2001
    Assignee: Monsanto Company
    Inventors: Stephen G. Rogers, Robert T. Fraley
  • Patent number: 6147278
    Abstract: The invention relates to novel plant plasmid vectors comprising geminivirus DNA or a portion thereof having inserted therein a heterologous DNA sequence or gene, to processes and DNA intermediates useful in producing said vectors and to methods utilizing such vectors to replicate and express heterologous DNA sequences or genes in plants. In some embodiments, methods and compositions are provided for Ti plasmid delivery of these novel vectors into plants. In other embodiments, methods and compositions are provided which allow for the generation of geminivirus DNA containing plant plasmids in stably transformed plants. In still other embodiments, methods and compositions are provided for replicating and expressing heterologous DNA sequences or genes in plants employing the geminivirus DNA containing vectors of the present invention without causing disease symptoms.
    Type: Grant
    Filed: March 3, 1999
    Date of Patent: November 14, 2000
    Assignee: Monsanto Company
    Inventors: Stephen G. Rogers, Leslie Brand, Robert B. Horsch, Robert T. Fraley, James Scott Elmer, David Bisaro
  • Patent number: 5530196
    Abstract: In one aspect the present invention relates to the use of viral promoters in the expression of chimeric genes in plant cells. In another aspect this invention relates to chimeric genes which are capable of being expressed in plant cells, which utilize promoter regions derived from viruses which are capable of infecting plant cells. One such virus comprises the cauliflower mosaic virux (CaMV). Two different promoter regions have been derived from the CaMV genome and ligated to heterologous coding sequences to form chimeric genes. These chimeric genes have been shown to be expressed in plant cells. This invention also relates to plant cells, plant tissue, and differentiated plants which contain and express the chimeric genes of this invention.
    Type: Grant
    Filed: September 2, 1994
    Date of Patent: June 25, 1996
    Assignee: Monsanto Company
    Inventors: Robert T. Fraley, Robert B. Horsch, Stephen G. Rogers
  • Patent number: 5378619
    Abstract: A full-length transcript promoter from figwort mosaic virus (FMV) is identified and its DNA sequence given. The promoter functions as a strong and uniform promoter for chimeric genes inserted into plant cells. This strong promoter function is exhibited by a histochemical assay in floral buds and by reproductive scores of transgenic plants including the promoter. The promoter preferably includes a 5' leader sequence that may be from the FMV itself or from a heterologous source with respect to the promoter. The promoter is used in a plant cassette vector, a chimeric gene and in methods for transforming plant cells to obtain transgenic plants, plant cells or seeds incorporating the FMV promoter.
    Type: Grant
    Filed: December 22, 1993
    Date of Patent: January 3, 1995
    Assignee: Monsanto Company
    Inventor: Stephen G. Rogers
  • Patent number: 5352605
    Abstract: In one aspect the present invention relates to the use of viral promoters in the expression of chimeric genes in plant cells. In another aspect this invention relates to chimeric genes which are capable of being expressed in plant cells, which utilize promoter regions derived from viruses which are capable of infecting plant cells. One such virus comprises the cauliflower mosaic virus (CaMV). Two different promoter regions have been derived from the CaMV genome and ligated to heterologous coding sequences to form chimeric genes. These chimeric genes have been shown to be expressed in plant cells. This invention also relates to plant cells, plant tissue, and differentiated plants which contain and express the chimeric genes of this invention.
    Type: Grant
    Filed: October 28, 1993
    Date of Patent: October 4, 1994
    Assignee: Monsanto Company
    Inventors: Robert T. Fraley, Robert B. Horsch, Stephen G. Rogers
  • Patent number: 5349124
    Abstract: This present invention describes genetically transformed lettuce cells and transgenic lettuce plants which exhibit toxicity to Lepidopteran larvae.
    Type: Grant
    Filed: February 13, 1992
    Date of Patent: September 20, 1994
    Assignee: Monsanto Company
    Inventors: David A. Fischhoff, Stephen G. Rogers
  • Patent number: 5188642
    Abstract: This invention involves a cloning or expression vector comprising a gene which encodes 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) polypeptide which, when expressed in a plant cell contains a chloroplast transit peptide which allows the polypeptide, or an enzymatically active portion thereof, to be transported from the cytoplasm of the plant cell into a chloroplast in the plant cell, and confers a substantial degree of glyphosate resistance upon the plant cell and plants regenerated therefrom.The EPSPS coding sequence may be ligated to a strong promoter, such as the 35S promoter from cauliflower mosaic virus, to create a chimeric gene. Such genes can be inserted into plant transformation vectors, and subsequently introduced into plant cells. Plant cells transformed using such genes and plants regenerated therefrom have been shown to exhibit a substantial degree of glyphosate resistance.
    Type: Grant
    Filed: February 12, 1990
    Date of Patent: February 23, 1993
    Assignee: Monsanto Company
    Inventors: Dilip M. Shah, Stephen G. Rogers, Robert B. Horsch, Robert T. Fraley
  • Patent number: 5034322
    Abstract: This invention relates to chimeric genes which are capable of being expressed in plant cells. Such genes contain (a) a promoter region derived in a gene which is expressed in plant cells, such as the nopaline synthase gene; (b) a coding or structural sequence which is heterologous with respect to the promoter region; and (c) an appropriate 3' non-translated region. Such genes have been used to create antibiotic-resistant plant cells; they are also useful for creating herbicide-resistant plants, and plants which contain mammalian polypeptides.
    Type: Grant
    Filed: April 5, 1989
    Date of Patent: July 23, 1991
    Assignee: Monsanto Company
    Inventors: Stephen G. Rogers, Robert T. Fraley
  • Patent number: 4948731
    Abstract: A recombinant plasmid which may be used for propagation of cloned cDNAs and also for the in vitro synthesis of RNA which is an exact copy of the natural sequence, wherein the transcript is devoid of vector-derived sequence. The novel vector was generated de novo by genetic engineering procedures using a synthetic double strand oligodeoxyribonucleotide fragment and a larger DNA fragment derived from plasmid pSP64. The vector, plasmid pHST-O, carried by Escherichia coli HB101, deposited with the ATCC on Dec.
    Type: Grant
    Filed: August 5, 1986
    Date of Patent: August 14, 1990
    Assignee: Massachusetts Institute of Technology
    Inventors: Lee Gehrke, Robert T. Fraley, Stephen G. Rogers
  • Patent number: 4940835
    Abstract: This invention involves a cloning or expression vector comprising a gene which encodes 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) polypeptide which, when expressed in a plant cell contains a chloroplast transit peptide which allows the polypeptide, or an enzymatically active portion thereof, to be transported from the cytoplasm of the plant cell into a chloroplast in the plant cell, and confers a substantial degree of glyphosate resistance upon the plant cell and plants regenerated therefrom.The EPSPS coding sequence may be ligated to a strong promoter, such as the 35S promoter from cauliflower mosaic virus, to create a chimeric gene. Such genes can be inserted into plant transformation vectors, and subsequently introduced into plant cells. Plant cells transformed using such genes and plants regenerated therefrom have been shown to exhibit a substantial degree of glyphosate resistance.
    Type: Grant
    Filed: July 7, 1986
    Date of Patent: July 10, 1990
    Assignee: Monsanto Company
    Inventors: Dilip M. Shah, Stephen G. Rogers, Robert B. Horsch, Robert T. Fraley